<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifty patients with cervical <z:e sem="disease" ids="C0037933" disease_type="Disease or Syndrome" abbrv="">dorsopathy</z:e> with the <z:e sem="disease" ids="C0042560" disease_type="Disease or Syndrome" abbrv="">vertebral artery syndrome</z:e> were studied using clinical scales (neurological deficit, psychoemotional disturbances) and laboratory methods (parameters of oxidant stress) </plain></SENT>
<SENT sid="1" pm="."><plain>The correlations between the oxidant stress and the dynamics of neurological syndromes and psychoemotional disturbances as well as the efficacy and safety of their treatment with <z:chebi fb="11" ids="22586">antioxidants</z:chebi> (mexiprim) were determined </plain></SENT>
</text></document>